Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE . Rev Alerg Mex [Internet]. 2025 Sep. 30 [cited 2026 Sep. 23];72(3):221-2. Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1505